Ingredion/$INGR
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Ingredion
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins. The company plans to acquire Tate & Lyle in an all-cash deal that should close in 2027.
- Ticker
- $INGR
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 11,200
- Headquarters
- Westchester, United States
- Website
- www.ingredion.com
Ingredion Metrics
BasicAdvanced
$6B
10.33
$9.20
0.61
$3.28
3.45%
Price and volume
Market cap
$6B
Beta
0.61
52-week high
$123.49
52-week low
$93.72
Average daily volume
670K
Dividend rate
$3.28
Financial strength
Current ratio
2.798
Quick ratio
1.857
Long term debt to equity
0.385
Total debt to equity
0.394
Dividend payout ratio (TTM)
35.47%
Interest coverage (TTM)
58.13%
Profitability
EBITDA (TTM)
1,154
Gross margin (TTM)
23.73%
Net profit margin (TTM)
8.21%
Operating margin (TTM)
12.89%
Effective tax rate (TTM)
26.68%
Revenue per employee (TTM)
$640,000
Management effectiveness
Return on assets (TTM)
7.33%
Return on equity (TTM)
13.69%
Valuation
Price to earnings (TTM)
10.332
Price to revenue (TTM)
0.838
Price to book
1.33
Price to tangible book (TTM)
1.83
Price to free cash flow (TTM)
17.022
Free cash flow yield (TTM)
5.87%
Free cash flow per share (TTM)
5.586
Dividend yield (TTM)
3.45%
Forward dividend yield
3.45%
Growth
Revenue change (TTM)
-1.38%
Earnings per share change (TTM)
-10.00%
3-year revenue growth (CAGR)
-4.24%
10-year revenue growth (CAGR)
2.46%
3-year earnings per share growth (CAGR)
2.39%
10-year earnings per share growth (CAGR)
3.94%
3-year dividend per share growth (CAGR)
4.92%
10-year dividend per share growth (CAGR)
6.18%
What the Analysts think about Ingredion
Analyst ratings (Buy, Hold, Sell) for Ingredion stock.
Analyst projections of the future price of Ingredion stock.
Bulls say / Bears say
Texture & Healthful Solutions delivered its ninth consecutive quarter of volume growth, with second-quarter sales up 5% and operating income up 5%. Demand for clean-label, texture, sugar-reduction and protein-fortification products supports Ingredion’s shift towards higher-value ingredients. (Ingredion)
The Argo plant exited June at normal production rates across its major operating units, and US/Canada performance improved sequentially during the quarter. If that recovery holds, the largest operational drag on 2026 earnings should fade while the company’s reaffirmed adjusted EPS guidance remains achievable. (StockAnalysis, Ingredion)
The proposed Tate & Lyle acquisition would broaden Ingredion’s specialty formulation offering and is expected to add about $130 million of annual run-rate cost synergies by 2030. Tate & Lyle shareholders have approved the deal, reducing one execution hurdle ahead of the planned second-half 2027 completion. (Ingredion, Ingredion)
Profitability is under pressure even where demand is healthy: second-quarter gross margin fell to 23% from 26% and adjusted operating income declined 5%. Tapioca root prices have risen more than 40% since the start of 2026, so price increases may take time to recover the higher costs. (Ingredion, StockAnalysis)
The legacy US/Canada business remains a material earnings weakness: Ingredion expects full-year operating income there to fall 20% to 25%, reflecting Argo-related disruption, softer volumes and unfavourable price mix. Mexican peso strength is also expected to push LATAM operating income down by low single digits, limiting the benefit from specialty growth. (Ingredion)
Tate & Lyle would materially increase financial and execution risk: Ingredion expects pro forma net leverage of about 3.0 times adjusted EBITDA at completion, while the transaction carries roughly $175 million of one-off costs to achieve the synergies. Regulatory approvals are still outstanding, and the $130 million synergy target is not expected to be fully realised until 2030. (Ingredion, SEC)
Data summarised monthly by Lightyear AI. Last updated on 25 Sept 2026.
Ingredion Financial Performance
Revenues and expenses
Ingredion Earnings Performance
Company profitability
Upcoming events
Ingredion News
AllArticlesVideos
Funds containing Ingredion
AllUSDGBPEUR
Fund name | Fund size | $INGR weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.17% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.17% |
iShares MSCI World Small Cap$WSML | $9B | 0.06% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.06% |
iShares MSCI World Small Cap£WLDS | £6.7B | 0.06% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.